228 related articles for article (PubMed ID: 24320998)
1. Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582).
Hennessy EJ; Adam A; Aquila BM; Castriotta LM; Cook D; Hattersley M; Hird AW; Huntington C; Kamhi VM; Laing NM; Li D; MacIntyre T; Omer CA; Oza V; Patterson T; Repik G; Rooney MT; Saeh JC; Sha L; Vasbinder MM; Wang H; Whitston D
J Med Chem; 2013 Dec; 56(24):9897-919. PubMed ID: 24320998
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
[TBL] [Abstract][Full Text] [Related]
3. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.
Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S
J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838
[TBL] [Abstract][Full Text] [Related]
4. Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization.
Lecis D; Mastrangelo E; Belvisi L; Bolognesi M; Civera M; Cossu F; De Cesare M; Delia D; Drago C; Manenti G; Manzoni L; Milani M; Moroni E; Perego P; Potenza D; Rizzo V; Scavullo C; Scolastico C; Servida F; Vasile F; Seneci P
Bioorg Med Chem; 2012 Nov; 20(22):6709-23. PubMed ID: 23062821
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activity.
Perez HL; Chaudhry C; Emanuel SL; Fanslau C; Fargnoli J; Gan J; Kim KS; Lei M; Naglich JG; Traeger SC; Vuppugalla R; Wei DD; Vite GD; Talbott RL; Borzilleri RM
J Med Chem; 2015 Feb; 58(3):1556-62. PubMed ID: 25584393
[TBL] [Abstract][Full Text] [Related]
7. ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth.
Ward GA; Lewis EJ; Ahn JS; Johnson CN; Lyons JF; Martins V; Munck JM; Rich SJ; Smyth T; Thompson NT; Williams PA; Wilsher NE; Wallis NG; Chessari G
Mol Cancer Ther; 2018 Jul; 17(7):1381-1391. PubMed ID: 29695633
[TBL] [Abstract][Full Text] [Related]
8. Recognition of Smac-mimetic compounds by the BIR domain of cIAP1.
Cossu F; Malvezzi F; Canevari G; Mastrangelo E; Lecis D; Delia D; Seneci P; Scolastico C; Bolognesi M; Milani M
Protein Sci; 2010 Dec; 19(12):2418-29. PubMed ID: 20954235
[TBL] [Abstract][Full Text] [Related]
9. Smac mimetics as IAP antagonists.
Fulda S
Semin Cell Dev Biol; 2015 Mar; 39():132-8. PubMed ID: 25550219
[TBL] [Abstract][Full Text] [Related]
10. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2.
Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M
Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspases.
Zhang B; Nikolovska-Coleska Z; Zhang Y; Bai L; Qiu S; Yang CY; Sun H; Wang S; Wu Y
J Med Chem; 2008 Dec; 51(23):7352-5. PubMed ID: 19012392
[TBL] [Abstract][Full Text] [Related]
12. USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics.
Lee EW; Seong D; Seo J; Jeong M; Lee HK; Song J
Cell Death Differ; 2015 Sep; 22(9):1463-76. PubMed ID: 25613375
[TBL] [Abstract][Full Text] [Related]
13. Homo- and heterodimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part I: Synthesis.
Manzoni L; Belvisi L; Bianchi A; Conti A; Drago C; de Matteo M; Ferrante L; Mastrangelo E; Perego P; Potenza D; Scolastico C; Servida F; Timpano G; Vasile F; Rizzo V; Seneci P
Bioorg Med Chem; 2012 Nov; 20(22):6687-708. PubMed ID: 23036335
[TBL] [Abstract][Full Text] [Related]
14. Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines.
Polanski R; Vincent J; Polanska UM; Petreus T; Tang EK
Cell Death Dis; 2015 Oct; 6(10):e1893. PubMed ID: 26426685
[TBL] [Abstract][Full Text] [Related]
15. Design of small-molecule Smac mimetics as IAP antagonists.
Wang S
Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
[TBL] [Abstract][Full Text] [Related]
16. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
Moon JH; Shin JS; Hong SW; Jung SA; Hwang IY; Kim JH; Choi EK; Ha SH; Kim JS; Kim KM; Hong DW; Kim D; Kim YS; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Hattersley M; Jin DH; Kim TW
Oncotarget; 2015 Sep; 6(29):26895-908. PubMed ID: 26314849
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors.
Wang J; Li W
J Pharmacol Exp Ther; 2014 May; 349(2):319-29. PubMed ID: 24623800
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).
Flygare JA; Beresini M; Budha N; Chan H; Chan IT; Cheeti S; Cohen F; Deshayes K; Doerner K; Eckhardt SG; Elliott LO; Feng B; Franklin MC; Reisner SF; Gazzard L; Halladay J; Hymowitz SG; La H; LoRusso P; Maurer B; Murray L; Plise E; Quan C; Stephan JP; Young SG; Tom J; Tsui V; Um J; Varfolomeev E; Vucic D; Wagner AJ; Wallweber HJ; Wang L; Ware J; Wen Z; Wong H; Wong JM; Wong M; Wong S; Yu R; Zobel K; Fairbrother WJ
J Med Chem; 2012 May; 55(9):4101-13. PubMed ID: 22413863
[TBL] [Abstract][Full Text] [Related]
19. Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells.
Sun H; Lu J; Liu L; Yang CY; Wang S
ACS Chem Biol; 2014 Apr; 9(4):994-1002. PubMed ID: 24521431
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.
Bae I; Kim D; Choi J; Kim J; Kim M; Park B; Kim YH; Ahn YG; Hyung Kim H; Kim DK
Bioorg Med Chem Lett; 2021 Feb; 34():127676. PubMed ID: 33166687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
